UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Changes in causes of death in systemic sclerosis, 1972–2002

Annals of the rheumatic diseases, 2007-07, Vol.66 (7), p.940-944

2007

Volltextzugriff (PDF)

X chromosome gene methylation in peripheral lymphocytes from monozygotic twins discordant for scleroderma

Clinical and experimental immunology, 2012-09, Vol.169 (3), p.253-262

2012

Volltextzugriff (PDF)

Criteria for the classification of early systemic sclerosis

Journal of rheumatology, 2001-07, Vol.28 (7), p.1573

2001

Volltextzugriff (PDF)

Assessment of disease severity and prognosis

Clinical and experimental rheumatology, 2003, Vol.21 (3 Suppl 29), p.S42

2003

Volltextzugriff (PDF)

Age-specific Incidence Rates of Myocardial Infarction and Angina in Women with Systemic Lupus Erythematosus: Comparison with the Framingham Study

American journal of epidemiology, 1997-03, Vol.145 (5), p.408-415

1997

Volltextzugriff (PDF)

Development and initial validation of the Localized Scleroderma Skin Damage Index and Physician Global Assessment of disease Damage: a proof-of-concept study

Rheumatology (Oxford, England), 2010-02, Vol.49 (2), p.373-381

2010

Volltextzugriff (PDF)

Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial

Annals of the rheumatic diseases, 2011-01, Vol.70 (1), p.32-38

2011

Volltextzugriff (PDF)

Long-term outcomes of scleroderma renal crisis

Annals of internal medicine, 2000-10, Vol.133 (8), p.600

2000

Volltextzugriff (PDF)

Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma

Annals of the rheumatic diseases, 2011-01, Vol.70 (1), p.104-109

2011

Volltextzugriff (PDF)

Minimally important difference in diffuse systemic sclerosis: results from the d-penicillamine study

Annals of the rheumatic diseases, 2006-10, Vol.65 (10), p.1325-1329

2006

Volltextzugriff (PDF)

There is a need for new systemic sclerosis subset criteria. A content analytic approach

Scandinavian journal of rheumatology, 2018-01, Vol.47 (1), p.62-70

2018

Volltextzugriff (PDF)

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial

Annals of internal medicine, 2000-03, Vol.132 (6), p.425

2000

Volltextzugriff (PDF)

A disease severity scale for systemic sclerosis: development and testing

Journal of rheumatology, 1999-10, Vol.26 (10), p.2159

1999

Volltextzugriff (PDF)

The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis

Journal of rheumatology, 1998-01, Vol.25 (1), p.84

1998

Volltextzugriff (PDF)

Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis

Journal of rheumatology, 1995-07, Vol.22 (7), p.1281

1995

Volltextzugriff (PDF)

Raynaud's phenomenon: a proposal for classification

Clinical and experimental rheumatology, 1992-09, Vol.10 (5), p.485

1992

Volltextzugriff (PDF)

Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study

Annals of internal medicine, 1994-02, Vol.120 (3), p.199

1994

Volltextzugriff (PDF)

The assessment of the patient with systemic sclerosis. Introduction

Clinical and experimental rheumatology, 2003, Vol.21 (3 Suppl 29), p.S2

2003

Volltextzugriff (PDF)

Scleroderma (systemic sclerosis): classification, subsets and pathogenesis

Journal of rheumatology, 1988-02, Vol.15 (2), p.202

1988

Volltextzugriff (PDF)

AB0840 Scleroderma classification criteria: Disease-specific methods for valid case comparisons

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.686-686

2013

Volltextzugriff (PDF)

Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): A high risk association

The American heart journal, 1993, Vol.125 (1), p.194-203

1993

Volltextzugriff (PDF)

Antiphospholipid antibodies in pediatric systemic lupus erythematosus

Pediatrics (Evanston), 1995-12, Vol.96 (6), p.1040-1045

1995

Volltextzugriff (PDF)

Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors

Annals of internal medicine, 1990-09, Vol.113 (5), p.352

1990

Volltextzugriff (PDF)

Autoantibody reactive with RNA polymerase III in systemic sclerosis

Annals of internal medicine, 1993-11, Vol.119 (10), p.1005

1993

Volltextzugriff (PDF)

Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States

Journal of rheumatology, 1989-04, Vol.16 (4), p.427

1989

Volltextzugriff (PDF)

1 – 25 von 469

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(284)
Mit Volltextzugriff
(322)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(468)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Humans
(331)
Science & Technology
(314)
Life Sciences & Biomedicine
(312)
Female
(216)
Rheumatology
(216)
Biological And Medical Sciences
(198)
Medical Sciences
(197)
Male
(190)
Middle Aged
(170)
Adult
(165)
Aged
(97)
Scleroderma, Systemic - Complications
(76)
Scleroderma, Systemic - Immunology
(58)
Systemic Sclerosis
(57)
Scleroderma
(53)
Adolescent
(48)
General & Internal Medicine
(47)
Medicine, General & Internal
(42)
Diseases Of The Osteoarticular System
(38)
Scleroderma, Systemic - Drug Therapy
(37)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Changes in causes of death in systemic sclerosis, 1972–2002

X chromosome gene methylation in peripheral lymphocytes from monozygotic twins discordant for scleroderma

Criteria for the classification of early systemic sclerosis

Assessment of disease severity and prognosis

Age-specific Incidence Rates of Myocardial Infarction and Angina in Women with Systemic Lupus Erythematosus: Comparison with the Framingham Study

Development and initial validation of the Localized Scleroderma Skin Damage Index and Physician Global Assessment of disease Damage: a proof-of-concept study

Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial

Long-term outcomes of scleroderma renal crisis

Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma

Minimally important difference in diffuse systemic sclerosis: results from the d-penicillamine study

There is a need for new systemic sclerosis subset criteria. A content analytic approach

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial

A disease severity scale for systemic sclerosis: development and testing

The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis

Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis

Raynaud's phenomenon: a proposal for classification

Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study

The assessment of the patient with systemic sclerosis. Introduction

Scleroderma (systemic sclerosis): classification, subsets and pathogenesis

AB0840 Scleroderma classification criteria: Disease-specific methods for valid case comparisons

Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): A high risk association

Antiphospholipid antibodies in pediatric systemic lupus erythematosus

Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors

Autoantibody reactive with RNA polymerase III in systemic sclerosis

Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States

Suchergebnisse filtern